UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Association of an HLA-DQ allele with clinical tuberculosis

JAMA : the journal of the American Medical Association, 1998-01, Vol.279 (3), p.226

1998

Volltextzugriff (PDF)

MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India

Tissue antigens, 1996-12, Vol.48 (6), p.668-672

1996

Volltextzugriff (PDF)

Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing

Tissue antigens, 1996-06, Vol.47 (6), p.512-518

1996

Volltextzugriff (PDF)

Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods

Tissue antigens, 1997-10, Vol.50 (4), p.387-394

1997

Volltextzugriff (PDF)

A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories

Nature neuroscience, 2001-03, Vol.4 (3), p.289-296

2001

Volltextzugriff (PDF)

MAPK, CREB and zif268 are all required for the consolidation of recognition memory

Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2003-04, Vol.358 (1432), p.805-814

2003

Volltextzugriff (PDF)

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma

Cancer, 2006-06, Vol.106 (11), p.2437-2444

2006

Volltextzugriff (PDF)

Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours

BMJ (Online), 2010-06, Vol.340, p.c2573

2010

Volltextzugriff (PDF)

Changes in sexual behaviours: from secular trends to public health policies

AIDS (London), 2010-05, Vol.24 (8), p.1185-1191

2010

Volltextzugriff (PDF)

Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy

Clinical genetics, 2018-07, Vol.94 (1), p.132-140

2018

Volltextzugriff (PDF)

1096 The PARP14 inhibitor RBN-3143 suppresses skin inflammation in preclinical models

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S188-S188

2023

Volltextzugriff (PDF)

Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France

Sexually transmitted infections, 2010-08, Vol.86 (4), p.263-270

2010

Volltextzugriff (PDF)

Amylose nodulaire cutanée AL, syndrome de CREST et Sjogrën

La revue de medecine interne, 2019-06, Vol.40, p.A166-A166

2019

Volltextzugriff (PDF)

162 Drug–drug interaction predictions for MLN2480, an investigational pan-RAF inhibitor, based on nonclinical data

European journal of cancer (1990), 2014-11, Vol.50, p.54-55

2014

Volltextzugriff (PDF)

Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy

Clinical genetics, 2018-04, Vol.94 (1), p.132-140

2018

Volltextzugriff (PDF)

Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France

Human mutation, 2000-08, Vol.16 (2), p.143-156

2000

Volltextzugriff (PDF)

Lymphome à grandes cellules ALK1 négatif CD 30+ avec atteintes ganglionnaire et cutanée sous dupilumab

Annales de dermatologie et de vénéréologie, 2018-12, Vol.145 (12), p.S272-S273

2018

Volltextzugriff (PDF)

Excitation of high energy levels under laser exposure of suspensions of nanoparticles in liquids

Applied surface science, 2007-12, Vol.254 (4), p.1022-1026

2007

Volltextzugriff (PDF)

The use of low-nuclearity oxoperoxo molybdenum species to achieve high dispersions on zirconia materials

Applied catalysis. A, General, 2007-05, Vol.325 (1), p.140-153

2007

Volltextzugriff (PDF)

First-in-human, multicenter, dose-escalation, phase I study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced nonhematologic malignancies and melanoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS145-TPS145

2011

Volltextzugriff (PDF)

Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations

Human mutation, 1997, Vol.10 (2), p.135-154

1997

Volltextzugriff (PDF)

Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients

Clinical genetics, 1998-05, Vol.53 (5), p.362-368

1998

Volltextzugriff (PDF)

Combined liver-kidney transplantation in primary hyperoxaluria type 1

European journal of pediatrics, 1999-12, Vol.158 Suppl 2 (S2), p.S75-S080

1999

Volltextzugriff (PDF)

324 Clinical pharmacokinetics (PK), translational PK/pharmacodynamics (PD), and exposure–adverse events (AEs) relationship of MLN2480, an oral investigational pan-RAF kinase inhibitor

European journal of cancer (1990), 2014-11, Vol.50, p.105-106

2014

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(43)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(19)
Female
(11)
Male
(11)
Life Sciences
(8)
Adult
(7)
Animals
(7)
Biological And Medical Sciences
(7)
Immunology
(7)
Medical Sciences
(7)
Middle Aged
(7)
Aged
(6)
Genetics & Heredity
(6)
Molecular Sequence Data
(6)
Adolescent
(5)
Cell Biology
(5)
Hematology, Oncology And Palliative Medicine
(5)
Alleles
(4)
Amino Acid Sequence
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association of an HLA-DQ allele with clinical tuberculosis

MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India

Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing

Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods

A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

MAPK, CREB and zif268 are all required for the consolidation of recognition memory

Biologic and immunomodulatory events after CTLA‐4 blockade with ticilimumab in patients with advanced malignant melanoma

Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours

Changes in sexual behaviours: from secular trends to public health policies

Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy

1096 The PARP14 inhibitor RBN-3143 suppresses skin inflammation in preclinical models

Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France

Amylose nodulaire cutanée AL, syndrome de CREST et Sjogrën

162 Drug–drug interaction predictions for MLN2480, an investigational pan-RAF inhibitor, based on nonclinical data

Single, short in‐del, and copy number variations detection in monogenic dyslipidemia using a next‐generation sequencing strategy

Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France

Lymphome à grandes cellules ALK1 négatif CD 30+ avec atteintes ganglionnaire et cutanée sous dupilumab

Excitation of high energy levels under laser exposure of suspensions of nanoparticles in liquids

The use of low-nuclearity oxoperoxo molybdenum species to achieve high dispersions on zirconia materials

First-in-human, multicenter, dose-escalation, phase I study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced nonhematologic malignancies and melanoma

Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations

Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients

Combined liver-kidney transplantation in primary hyperoxaluria type 1

324 Clinical pharmacokinetics (PK), translational PK/pharmacodynamics (PD), and exposure–adverse events (AEs) relationship of MLN2480, an oral investigational pan-RAF kinase inhibitor

Suchergebnisse filtern